article thumbnail

Making Sense of the Latest Changes to the Market Access Landscape

PM360

However, Medicare will only be able to negotiate prices for 10 Part D drugs in 2026, another 15 Part D drugs in 2027, another 15 Part D and Part B drugs in 2028, and another 20 Part D and Part B drugs for 2029 and subsequent years.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

In 2019, UnitedHealth Group CEO David Wichmann indicated a plan to make Optum a $100B business by 2028, including by partnering with health systems for administrative services such as RCM and IT. As of January 2024, CVS reported the number of Aetna members being treated by Oak Street had doubled.

Retail 52
article thumbnail

Reaching for the gold standard of lung cancer screening

pharmaphorum

The goal set out by the NHSE Long Term Plan is ambitions: to have three quarters of cancers diagnosed at an early stage by 2028. As Krishna details, it is a task that cannot be achieved by siloed pharma and healthcare providers working in isolation. Forewarned is forearmed.